Phytoplant Research
About Phytoplant Research
Phytoplant Research is a Córdoba-based biotech company focused on cannabinoid research, extraction, and the development of standardized cannabis-derived active pharmaceutical ingredients (APIs). The company has developed proprietary cannabis genetics and extraction technologies for pharmaceutical applications. Phytoplant was acquired by Bionorica, one of Europe's leading phytopharmaceutical companies.
Key Facts
- 1Acquired by Bionorica, a leading European phytopharmaceutical company
- 2Develops proprietary cannabis genetics optimized for pharmaceutical use
- 3One of the earliest licensed cannabis research companies in Spain
- 4Holds AEMPS licenses for cannabis research and production
Frequently Asked Questions
What is Phytoplant's relationship with Bionorica?
Phytoplant was acquired by Bionorica SE, one of Europe's largest phytopharmaceutical companies. This partnership provides Phytoplant with resources and expertise in developing plant-based medicines at pharmaceutical scale.
What are cannabinoid APIs?
APIs (Active Pharmaceutical Ingredients) are the biologically active components in medicines. Phytoplant produces standardized cannabinoid APIs — purified, consistent cannabinoid compounds used as the active ingredients in cannabis-based pharmaceutical products.
Cannabis Laws
Products
- Standardized cannabinoid APIs
- Cannabis plant genetics
- Cannabinoid extracts for research
Specialties
Company Details
- Type
- Extraction
- Location
- Córdoba, Spain
- Founded
- 2008
- Publicly Traded
- No